BR9907847A - Agentes anti-inflamatórios seletivos para glucocorticóides - Google Patents

Agentes anti-inflamatórios seletivos para glucocorticóides

Info

Publication number
BR9907847A
BR9907847A BR9907847-3A BR9907847A BR9907847A BR 9907847 A BR9907847 A BR 9907847A BR 9907847 A BR9907847 A BR 9907847A BR 9907847 A BR9907847 A BR 9907847A
Authority
BR
Brazil
Prior art keywords
glucocorticoids
inflammatory agents
selective anti
mammal
compounds
Prior art date
Application number
BR9907847-3A
Other languages
English (en)
Inventor
Michael J Coughlan
Michael E Kort
James P Edwards
Todd K Jones
Original Assignee
Abbott Lab
Ligand Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab, Ligand Pharm Inc filed Critical Abbott Lab
Publication of BR9907847A publication Critical patent/BR9907847A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Cosmetics (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)

Abstract

"AGENTES ANTI-INFLAMATóRIOS SELETIVOS PARA GLUCOCORTICóIDES" Compostos possuindo a Fórmula (I) são úteis para antagonizar, reprimir, agonizar ou modular parcial ou completamente o receptor glucocorticóide em um mamífero e tratamento de doenças imunes, autoimunes e inflamatórias em um mamífero. São também reveladas composições farmacêuticas compreendendo os compostos da Fórmula (I) e os processos para inibir doenças imunes e autoimunes em um mamífero.
BR9907847-3A 1998-02-13 1999-02-15 Agentes anti-inflamatórios seletivos para glucocorticóides BR9907847A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US09/023,913 US6380207B2 (en) 1998-02-13 1998-02-13 Glucocortiocoid-selective antiinflammatory agents
PCT/US1999/003210 WO1999041257A1 (en) 1998-02-13 1999-02-15 Glucocorticoid-selective antiinflammatory agents

Publications (1)

Publication Number Publication Date
BR9907847A true BR9907847A (pt) 2001-01-09

Family

ID=21817891

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9907847-3A BR9907847A (pt) 1998-02-13 1999-02-15 Agentes anti-inflamatórios seletivos para glucocorticóides

Country Status (23)

Country Link
US (1) US6380207B2 (pt)
EP (1) EP1053240B1 (pt)
JP (1) JP2002503666A (pt)
KR (1) KR20010040940A (pt)
CN (1) CN1153771C (pt)
AT (1) ATE237620T1 (pt)
AU (1) AU760511B2 (pt)
BG (1) BG64213B1 (pt)
BR (1) BR9907847A (pt)
CA (1) CA2320911A1 (pt)
DE (1) DE69906938T2 (pt)
DK (1) DK1053240T3 (pt)
ES (1) ES2197618T3 (pt)
HU (1) HUP0100846A3 (pt)
IL (1) IL137509A0 (pt)
NO (1) NO20004052L (pt)
NZ (1) NZ506012A (pt)
PL (1) PL342999A1 (pt)
PT (1) PT1053240E (pt)
SK (1) SK284076B6 (pt)
TR (1) TR200002345T2 (pt)
WO (1) WO1999041257A1 (pt)
ZA (1) ZA99533B (pt)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6566372B1 (en) * 1999-08-27 2003-05-20 Ligand Pharmaceuticals Incorporated Bicyclic androgen and progesterone receptor modulator compounds and methods
ES2246292T3 (es) 2000-10-30 2006-02-16 Pfizer Products Inc. Moduladores de receptor glucocorticoide.
US7026484B2 (en) * 2001-02-23 2006-04-11 Ligand Pharmaceuticals Incorporated Tricyclic androgen receptor modulator compounds and methods
CA2473886C (en) 2002-01-22 2012-08-21 The Regents Of The University Of California Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof
KR100492913B1 (ko) * 2002-08-23 2005-06-03 주식회사 태평양 피부 감작 및 자극을 완화하는 피부 외용제 조성물
EP2298315A1 (en) 2002-08-28 2011-03-23 Harbor BioSciences, Inc. Therapeutic treatment methods
US20040220153A1 (en) * 2002-09-24 2004-11-04 Jost-Price Edward Roydon Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines
DE20301728U1 (de) * 2002-10-11 2004-03-11 Ligand Pharmaceuticals, Inc., San Diego 5-substituierte 7,9-Difluor-5H-Chromeno(3,4-f) -Chinolin-Verbindungen als selektive Progesteronrezeptormodulator-Verbindungen
AU2003258050A1 (en) * 2002-10-11 2004-05-04 Ligand Pharmaceuticals Incorporated 5-cycloalkenyl 5h-chromeno(3,4-f)quinoline derivatives as selective progesterone receptor modulator compounds
CA2501833A1 (en) * 2002-10-11 2004-04-22 Ligand Pharmaceuticals Incorporated 5-(1',1'-cycloalkyl/alkenyl)methylidene 1,2-dihydro-5h-chromeno[3,4-f]quinolines as selective progesterone receptor modulator compounds
US7235662B2 (en) * 2003-06-11 2007-06-26 Bristol-Myers Squibb Company Modulators of the glucocorticoid receptor and method
MXPA06001751A (es) * 2003-08-22 2006-05-12 Ligand Pharm Inc Derivados de 6-cicloamino-2-quinolinona como compuestos moduladores de receptor de androgeno.
TW200517114A (en) 2003-10-15 2005-06-01 Combinatorx Inc Methods and reagents for the treatment of immunoinflammatory disorders
DE602004031356D1 (de) 2003-11-21 2011-03-24 Zalicus Inc Verfahren und reagenzien zur behandlung von entzündlichen erkrankungen
US8519158B2 (en) 2004-03-12 2013-08-27 Ligand Pharmaceuticals Incorporated Androgen receptor modulator compounds and methods
BRPI0609191B8 (pt) * 2005-06-17 2021-05-25 Ligand Pharm Inc métodos e compostos moduladores de receptor de androgênio
WO2007025303A2 (en) 2005-08-26 2007-03-01 The Regents Of The University Of California Non-steroidal antiandrogens
JP2009514969A (ja) 2005-11-09 2009-04-09 コンビナトアールエックス インコーポレーティッド 医学的状態を治療するための方法、組成物、およびキット
CA2632531A1 (en) * 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Propionamide compounds as antiinflammatory agents
WO2007065828A1 (en) * 2005-12-09 2007-06-14 F. Hoffmann-La Roche Ag Glucocorticoid receptor modulators as antiinflammatory agents
US8269612B2 (en) 2008-07-10 2012-09-18 Black & Decker Inc. Communication protocol for remotely controlled laser devices
US20100092479A1 (en) * 2008-08-18 2010-04-15 Combinatorx (Singapore) Pte. Ltd. Compositions and methods for treatment of viral diseases
US9908182B2 (en) 2012-01-30 2018-03-06 Black & Decker Inc. Remote programming of a power tool
US20130327552A1 (en) 2012-06-08 2013-12-12 Black & Decker Inc. Power tool having multiple operating modes
US8919456B2 (en) 2012-06-08 2014-12-30 Black & Decker Inc. Fastener setting algorithm for drill driver
US10011006B2 (en) 2013-08-08 2018-07-03 Black & Decker Inc. Fastener setting algorithm for drill driver
WO2020214834A1 (en) 2019-04-19 2020-10-22 Ligand Pharmaceuticals Inc. Crystalline forms and methods of producing crystalline forms of a compound

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5696130A (en) 1994-12-22 1997-12-09 Ligand Pharmaceuticals Incorporated Tricyclic steroid receptor modulator compounds and methods
EP1043325B1 (en) 1994-12-22 2004-06-16 Ligand Pharmaceuticals Incorporated Steroid receptor modulator compounds and methods
US5693133A (en) 1995-05-10 1997-12-02 Akzo Nobel Nv Asbestos free roof coatings

Also Published As

Publication number Publication date
ATE237620T1 (de) 2003-05-15
US6380207B2 (en) 2002-04-30
IL137509A0 (en) 2001-07-24
HUP0100846A3 (en) 2003-03-28
SK11962000A3 (sk) 2001-03-12
EP1053240B1 (en) 2003-04-16
TR200002345T2 (tr) 2000-11-21
DE69906938D1 (de) 2003-05-22
EP1053240A1 (en) 2000-11-22
NO20004052D0 (no) 2000-08-11
HK1033309A1 (en) 2001-08-24
DK1053240T3 (da) 2003-08-11
KR20010040940A (ko) 2001-05-15
PL342999A1 (en) 2001-07-16
SK284076B6 (sk) 2004-09-08
CA2320911A1 (en) 1999-08-19
CN1153771C (zh) 2004-06-16
CN1297451A (zh) 2001-05-30
JP2002503666A (ja) 2002-02-05
NO20004052L (no) 2000-10-12
PT1053240E (pt) 2003-09-30
BG64213B1 (bg) 2004-05-31
ZA99533B (en) 1999-07-26
BG104698A (en) 2001-05-31
WO1999041257A1 (en) 1999-08-19
ES2197618T3 (es) 2004-01-01
NZ506012A (en) 2003-03-28
US20010049377A1 (en) 2001-12-06
DE69906938T2 (de) 2004-02-26
AU2600399A (en) 1999-08-30
AU760511B2 (en) 2003-05-15
HUP0100846A2 (hu) 2001-09-28

Similar Documents

Publication Publication Date Title
BR9907847A (pt) Agentes anti-inflamatórios seletivos para glucocorticóides
BR0112160A (pt) Agentes antiinflamatórios seletivos para glicocorticóides
BR9907788A (pt) Agentes antiinflamatórios seletivos paraglicocorticóides
BR9916746A (pt) Compostos anti-inflamatórios que inibem adesão de célula
BR9910864A (pt) Compostos anti-inflamatórios para inibição de aderência celular
EP1034164A4 (en) BETA-ALANINE DERIVATIVES AS CELL ADHESION INHIBITORS
FI973087A7 (fi) Soluadheesion inhibiittoreita
BR9811099A (pt) Inibidores de urocinase
IT1214609B (it) Esosaminoglicani solfati depolimerizzati ad attivita'antitrombotica, fibrinolitica, antinfiammatoria, loro procedimento di preparazione e composizioni farmaceutiche che li contengono.
EP1017382A4 (en) BIARYL ALKANIC ACIDS USED AS CELL ADHESION INHIBITORS
BR9917038A (pt) Composto, composição farmacêutica, método de modulação da atividade receptora de quimocinas, método de tratamento ou prevenção de doenças inflamatórias, método de tratamento ou prevenção de asma e método de tratamento ou prevenção de disfunções inflamatórias
BR9813028A (pt) Agonistas de prostaglandina e seu uso para tratar distúrbios nos ossos
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
BR9811585A (pt) Agonistas de vasopressinas tricìclicas
BR9916638A (pt) Compostos anti-inflamatórios e imuno-supressores inibidores de aderência celular
BR9907655A (pt) Derivados de ácido di-hidróxi-hexanóico
AU4179399A (en) Use of nmda antagonists and/or sodium channel antagonists for the treatment of inflammatory disorders
PT1100483E (pt) Agentes anti-inflamatorios selectivos para glicocorticoide
NO963331L (no) 5-Heteroarylindol-derivater som benzodiazepin-reseptorsete-agonister og antagonister
DE69819539D1 (de) Antithrombotische mittel
AU7470098A (en) Antithrombotic agents
EP0980366A4 (en) ANTITHROMOSIS

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 9A ANUIDADE

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO PUBLICADO NA RPI 1945 DE 15 - 04 - 2008.